Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Gemigliptin and Metformin in Healthy Mexican Males
NCT03310749Phase 1Completed
- Sponsor
- Stendhal Pharma
- Start
- Jan 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of gemigliptin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Stendhal Pharma. Primary endpoint: Gemigliptin AUCtau,ss Geometric Mean Ratio at Day 6. Started Jan 2016; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03310749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03310749.